Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation

Neuroscience Research

Volumn 44, Issue 4, 2002, Pages 391-403

  Sugawa, Makoto ^a,b   Sakurai, Yoko ^b   Ishikawa Ieda, Yasuko ^a   Suzuki, Hiroshi ^a   Asou, Hiroaki ^b,c  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Astrocyte proliferation; Erythropoietin; Oligodendrocyte maturation

Indexed keywords

ANTIBODY; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MYELIN; MYELIN BASIC PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ACCELERATION; ANIMAL CELL; ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; CELL LEVEL; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL TYPE; CENTRAL NERVOUS SYSTEM; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY; LIVER; MIXED CELL CULTURE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, DIFFERENTIATION; ASTROCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIA; PREGNANCY; RATS; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER;

EID: 0036890102     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(02)00161-X     Document Type: Article

References (61)

1. Armstrong R.C., Dorn H.H., Kufta C.V., Friedman E., Dubois-Dalcq M.E. Pre-oligodendrocytes from adult human CNS. J. Neurosci. 12:1992;1538-1547.
2. Barber D.L., Beattie B.K., Mason J.M., Nguyen M.H.H., Yoakim M., Neel B.G., D'Andrea A.D., Frank D.A. A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for docking model of STAT activation. Blood. 97:2001;2230-2237.
3. Barres B.A., Hart I., Coles H., Burne J., Voyvodic J., Richardson W., Raff M. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:1992;31-46.
4. Barres B.A., Schmid R., Sendtner M., Raff M. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 118:1993;283-295.
5. Barres B.A., Raff M.C. Axonal control of oligodendrocyte development. J. Cell Biol. 147:1999;1123-1128.
6. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood flow Metab. 19:1999;643-651.
7. Bhat S., Pfeiffer S.E. Stimulation of oliodendrocytes by extracts from astrocyte-enriched cultures. J. Neurosci. Res. 15:1986;19-27.
8. Bögler O., Wren D., Barnett S., Land H., Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocytes-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl. Acad. Sci. USA. 87:1990;6368-6372.
9. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., Cerami A. Erythropoietin cross the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA. 97:2000;10526-10531.
10. Chin K., Yu X., Beleslin-Cokic B., Liu C., Shen K., Mohrenweiser H.W., Noguchi C.T. Production and processing of erythropoietin receptor transcripts in brain. Brain Res. Mol. Brain Res. 81:2000;29-42.
11. Digicaylioglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., Gassmann M. Localization of specific erythropoietin binding site in defined areas of the mouse brain. Proc. Natl. Acad. Sci. USA. 92:1995;3717-3720.
12. Ellison J.A., Scully S.A., Vellis J. Evidence for neuronal regulation of oligodendrocyte development: Cellular localization of platelet-derived growth factor α a receptor and A-chain mRNA during cerebral cortex development in the rat. J. Neurosci. Res. 45:1996;28-39.
13. +GalC-oligodendrocyte progenitors. Dev. Bio. 159:1993;618-630.
14. Gard A.L., Burrel M.R., Pfeiffer S.E., Rudge J.S., Williams I.I.W.C. Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein. Development. 121:1995;2187-2197.
15. Genser J.M., Goldman J.E. In vivo characterization of endogenous proliferating cells in adult rat subcortical white matter. Glia. 17:1996;39-51.
16. Genser J.M., Goldman J.E. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron. 19:1997;197-203.
17. Hardy, R., Reynolds, R., 1991. Proliferation and differentiation potential of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development 111, 1061-1080.
18. Juul S.E., Anderson D.K., Li Y., Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediat. Res. 43:1998;40-49.
19. Juul S.E., Yachnis A.T., Rojiani A.M., Christensen R.D. Immunohitochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr. Dev. Pathol. 2:1999;148-158.
20. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227, 680-85.
21. LeVine S.M., Goldman J.E. Embryonic divergence of oligodendrocyte and astrocyte lineages in developing rat cerebrum. J. Neurosci. 8:1988;3992-4006.
22. LeVine S.M., Goldman J.E. Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum. J. Comp. Neurol. 277:1988;441-445.
23. Levison S.W., Goldman J.E. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron. 10:1993;201-212.
24. Levison S.W., Young G.M., Goldman J.E. Cycling cells in the adult rat neocortex preferentially generate oligodendroglia. J. Neurosci. Res. 57:1999;435-446.
25. Liu Z.Y., Chin K., Noguchi C.T. Tissue specific expression of human erythropoietin receptor transgenic mice. Dev. Bio. 166:1994;159-169.
26. Liu C., Shen K., Liu Z., Noguchi C.T. Regulated human erythropoietin receptor expression in mouse brain. J. Bio. Chem. 272:1997;32395-32400.
27. Marti H.H., Wenger R.H., Rivas L.A., Straaumann U., Digicaylioglu M., Henn V., Yonekawa Y., Bauer C., Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8:1996;666-676.
28. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., Sasaki R. A novel site of erythropoietin production: oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269:1994;19488-19493.
29. Mayer M., Bhaakoo K., Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development. 120:1994;143-153.
30. McKinnon R., Smith C., Behar T., Smith T., Dubbois-Dalcq M. Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia. 7:1993;245-254.
31. McMorris F., Dubois-Dalcq M. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 21:1988;199-209.
32. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 76:1997;105-116.
33. Nagai A., Nakagawa E., Hyun B., Choi B.Sc., Hatori K., Kobayashi S., Kim S.U. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes growth in culture. J. Neuropathol. Exp. Neurol. 60:2001;386-392.
34. Nakamura T., Ebihara I., Shimada N., Koide H. Elevated levels of erythropoietin in cerebrospinal fluid of depressed patients. Am. J. Med. Sci. 315:1998;199-201.
35. Nishiyama A., Yu M., Drazba J.A., Tuohy V.K. Normal and reactive NG2 glia cells are distinct from resting and activated microglia. J. Neursci. Res. 48:1997;299-312.
36. Noll E., Miller R.H. Oligodendrocyte precursors originate at the ventral ventricular zone dorsal to the ventral midline in the embryonic rat spinal cord. Development. 118:1993;563-573.
37. Oh L.Y.S., Yong V.W. Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix. Glia. 17:1996;237-253.
38. Ono K., Bansal R., Payne J., Rutishauser U., Miller R.H. Early development and dispersal of oligodendrocyte precursors in the embryonic chick spinal cord. Development. 121:1995;1743-1754.
39. Paterson J., Privat A., Ling A.E., Leblond C.P. Investigation of glial cells in semithin sections. III. Transformation of subependymal cells into glial cells, as shown by autoradiography of 3H-thymidine injection into the lateral ventricule of the brain young rats. J. Comp. Neurol. 149:1973;83-103.
40. Prineas J.W., Kwon E.E., Goldenberg P.Z., Ilyas A.A., Quarles R.H., Benjamins J.A., Sprinkle T.J. Multiple sclerosis: Oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 61:1989;489-503.
41. Prineas J.W., Barnard R.O., Kwon E.E., Sharer L.R., Cho E.S. Multiple sclerosis: remyelination of nascent lesion. Ann. Neurol. 33:1993;137-151.
42. Pringle N.P., Richardson W.D. A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may define the origin of oligodendrocyte lineage. Development. 117:1993;525-533.
43. Raible D.W., McMorris F.A. Cyclic AMP regulates the rate of differentiation of oligodendrocytes without changing the lineage commitment of their progenitors. Dev. Biol. 133:1989;437-446.
44. Raine C.S., Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 52:1993;199-204.
45. Raine C.S., Scheinberg L., Waltz J.M. Oligodendrocytes survival and proliferation in an active established lesion. Lab. Invest. 45:1981;534-546.
46. Robinson S., Miller R.H. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev. Biol. 216:1999;359-368.
47. Roy N.S., Wang S., Harrison-Restelli C., Benraiss A., Fraser R.A.R., Gravel M., Braun P.E., Goldman S.A. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J. Neurosci. 22:1999;9986-9995.
48. Sakanaka M., Wen T.-C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA. 95:1998;4635-4640.
49. Sakurai Y., Nishimura D., Yoshimura K., Tsuruo Y., Seiwa C., Asou H. Differentiation of oligodendrocyte occurs in contact with astrocyte. J. Neurosci. Res. 52:1998;17-26.
50. Sato-Bigbee C., Yu R.K. Presence of a camp response element binding protein in oligodendrocytes. J. Neurochem. 60:1993;2106-2110.
51. Sato-Bigbee C., Chan E.L.P., Yu R.K. Oligodendroglial cyclic AMP response element-binding protein: A member of the CREB family of transcription factors. J. Neurosci. Res. 38:1994;621-628.
52. Sato-Bigbee C., DeVries G.H. Treatment of oligodendrocytes with antisense deoxyoligonucleotide directed against CREB mRNA: Effect on the cyclic AMP-dependent induction of myelin basic protein expression. J. Neurosci. Res. 46:1996;98-107.
53. Skoff R.P. Myelin deficit in the Jimpy mouse may be due to cellular abnormalities in astroglia. Nature. 264:1976;560-562.
54. Sommer, I., Schacher, M., 1981. Monoclonal antibodies (01 to 04) to oligodendrocyte cell surfaces: an immunocytological study in the Central Nervous System. Dev. Biol. 83, 311-327.
55. Sturrock R.R. Light microscopic identification of immature glial cells in semithin section of the developing mouse corpus callosum. J. Anat. 122:1976;521-537.
56. Sugawa M., Ikeda S., Kushima Y., Takashima Y., Cynshi O. Oxidized low density lipoprotein caused CNS neuron cell death. Brain Res. 761:1997;165-172.
57. Warf B.C., Fok-Seang J., Miller R.H. Evidence for the ventral origin of oligodendrocyte precursors in the rat spinal cord. J. Neurosci. 11:1991;2477-2488.
58. Wolswijk G., Noble M. Cooperation between PDGF and FGF converts slowly dividing O2A progenitor cells to rapidly dividing cells with characteristics of O-2A perinatal progenitor cells. J. Cell Biol. 118:1992;889-900.
59. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18:1998;601-609.
60. Wu H., Lee S.H., Gao J., Liu X., Iruela-Arispe M.L. In activation of erythropoietin leads to defects in cardiac morphogenesis. Development. 126:1999;3597-3605.
61. Zhang S., Ge B., Duncan I.D. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc. Natl. Acad. Sci. USA. 96:1999;4089-4094.